Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates.
D000293:Adolescent; D001519:Behavior / Q000187:drug effects; D002395:Catecholamines / Q000652:urine; D004298:Dopamine / Q000652:urine; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000652:urine; D010648:Phenylacetates / Q000652:urine; D011680:Pupil / Q000187:drug effects; D005879:Tourette Syndrome / Q000188:drug therapy*; D014642:Vanilmandelic Acid / Q000652:urine
D002395:Catecholamines; D010648:Phenylacetates; D014642:Vanilmandelic Acid; D006220:Haloperidol; D004298:Dopamine; D009638:Norepinephrine